Psychiatry and Neurology, Neurology · New York, NY
NPI
1619948783
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
6
Hospital affiliations
5 E 98th St, First Floor
New York, NY, 10029
Phone (212) 241-7076
Groups this clinician bills Medicare through
Medicare paid, 2024
$452K
47,250 services
Medicare patients, 2024
549
Average age 75
Drug cost, 2024
$1.0M
2,650 prescriptions
Company payments, 2025
$82.33
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Miodrag Velickovic was code J0585 (injection, onabotulinumtoxina, 1 unit), 44,427 times for 89 patients. In total Miodrag Velickovic billed 47,250 services in 21 codes, and Medicare paid $452K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-06-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 44,427 | 89 | $4.89 | $217K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,094 | 468 | $14.29 | $16K |
| 99214 Office E&M - Established | Office | 532 | 272 | $109.13 | $58K |
| 99215 Office E&M - Established | Office | 440 | 222 | $153.26 | $67K |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 149 | 86 | $28.87 | $4,302 |
| 99205 Office E&M - New | Office | 149 | 149 | $193.31 | $29K |
| 64612 Musculoskeletal | Office | 95 | 28 | $178.38 | $17K |
| 64615 Musculoskeletal | Office | 81 | 27 | $149.65 | $12K |
| 95874 Musculoskeletal | Office | 80 | 31 | $69.59 | $5,567 |
| 99213 Office E&M - Established | Office | 61 | 40 | $77.01 | $4,698 |
| 64616 Musculoskeletal | Office | 59 | 21 | $187.70 | $11K |
| 99204 Office E&M - New | Office | 19 | 19 | $138.52 | $2,632 |
By year: 2022 $420K for 45,735 services; 2023 $417K for 43,732 services; 2024 $452K for 47,250 services.
Medicare prescription drug claims, 2024
In 2024, the drug Miodrag Velickovic prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 476 prescriptions and refills. In total Miodrag Velickovic wrote 2,650 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 476 | 1,005 | 135 | $13K |
| Memantine Hcl Generic | 181 | 419 | 53 | $7,113 |
| Donepezil Hcl Generic | 165 | 332 | 39 | $3,658 |
| Gabapentin Generic | 152 | 345 | 52 | $3,210 |
| Clonazepam Generic | 90 | 104 | 23 | $792 |
| Carbidopa-Levodopa-Entacapone Carbidopa/Levodopa/Entacapone | 89 | 170 | 21 | $19K |
| Pregabalin Generic | 65 | 91 | 12 | $3,334 |
| Amantadine Amantadine Hcl | 60 | 124 | 17 | $4,972 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 55 | 108 | 24 | $2,936 |
| Propranolol Hcl Generic | 55 | 134 | 22 | $1,464 |
| Galantamine Er Galantamine Hbr | 48 | 98 | 15 | $6,333 |
| Rivastigmine Generic | 48 | 72 | 14 | $6,907 |
| Lamotrigine Generic | 46 | 92 | Under 11 | $985 |
| Topiramate Generic | 43 | 91 | 16 | $636 |
| Primidone Generic | 43 | 84 | 13 | $1,950 |
Brand drugs: - claims; generic drugs: 2,318 claims; opioid claims: 27.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Miodrag Velickovic $82.33 ($82.33 in general payments such as food, travel and fees) from 1 company. The largest payer was Pfizer Inc. with $82.33.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 4 | $82.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.